Westlake Chemical Partners (WLKP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Reported Q3 2024 net income of $18.1M ($0.51 per unit), up $4.9M year-over-year, with distributable cash flow at its highest since 2022, driven by higher third-party ethylene sales prices and margins.
Celebrated 10th anniversary as a publicly traded MLP, with 41 consecutive distributions and a 71% increase in quarterly distribution since IPO.
Operates as a limited partnership supplying ethylene to Westlake Corporation, ensuring stable, predictable cash flows and growth potential through capacity expansions and acquisitions.
Deferred the planned turnaround at the Petro 1 ethylene unit to Q1 2025 to capitalize on favorable market conditions and maximize third-party sales margins.
Net income for Q3 2024 was $104.1M on net sales of $277.0M, up $23.2M year-over-year despite a $44.7M sales decline, driven by higher third-party sales and lower feedstock costs.
Financial highlights
Q3 2024 revenue: $277M, gross profit: $116.9M (42.2% margin), EBITDA: $139.1M, and distributable cash flow: $17.9M, all up year-over-year.
Q3 2024 net income increased by $5M compared to Q3 2023; net income per limited partner unit: $0.51, up from $0.37 in Q3 2023.
Distributions declared per unit: $0.4714 for Q3 2024, 41st consecutive quarterly distribution.
Trailing twelve-month coverage ratio improved to 1.03x from 0.96x sequentially; cumulative coverage ratio since IPO: 1.08x.
Ended Q3 2024 with $170M in consolidated cash and investments; long-term debt totaled $399.7M, all variable rate.
Outlook and guidance
No planned turnarounds for the remainder of 2024; Petro 1 turnaround scheduled for Q1 2025, expected to last about 55 days.
Most planned third-party ethylene sales for 2024 already booked; expect moderation in distributable cash flow in Q4 due to increased maintenance capital for Petro 1 turnaround.
Fourth quarter 2024 expected to see lower third-party ethylene sales prices and margins, but minimal impact due to limited remaining sales volume.
Ethylene sales agreement with Westlake for 95% of OpCo's production ensures stable, predictable cash flows.
Growth levers include increasing OpCo ownership, organic expansions, acquisitions, and potential margin enhancements.
Latest events from Westlake Chemical Partners
- Registering $500M in securities and 1.4M units for resale to fund growth and provide liquidity.WLKP
Registration Filing4 Mar 2026 - Stable 2025 results with distributions intact; 2026 outlook strong as no turnarounds planned.WLKP
Q4 202524 Feb 2026 - Q2 net income and margins rose, distributions stayed strong, and a Q3 turnaround is planned.WLKP
Q2 20242 Feb 2026 - Q3 2025 saw lower net income but stable distributions and renewed sales agreements.WLKP
Q3 20258 Jan 2026 - Q2 2025 net income was $14.6M; cash flow set to recover after the Petro 1 turnaround.WLKP
Q2 20258 Jan 2026 - Q1 2025 profit and cash flow fell on the Petro 1 turnaround, but distributions remained stable.WLKP
Q1 20258 Jan 2026 - 2024 net income rose on higher ethylene margins; 2025 turnaround to impact coverage.WLKP
Q4 20248 Jan 2026